Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
manufacturing problem
Manufacturing
Manufacturing issues prompt FDA rejection of Hyloris antiviral
The FDA has rejected Hyloris' antiviral valacyclovir, an oral suspension for infections caused by herpes simplex, because of manufacturing issues.
Kevin Dunleavy
Mar 13, 2026 8:40am
Flooding halts manufacturing at Alembic Pharmaceuticals plant
Oct 5, 2023 8:45am
Pfizer's Vyndaqel hits supply snag in Korea: report
Jun 14, 2022 7:55am
Fired whistleblower who warned of plant violations, sues Lilly
Jun 7, 2022 9:45am
FDA has OK'd Incyte's manufacturing tweaks, company says
May 3, 2022 11:45am
Complaint reveals quality woes with Incyte's eczema cream—again
Apr 19, 2022 9:40am
